Literature DB >> 15558242

Stimulation of cellular free Ca2+ elevation and inhibition of store-operated Ca2+ entry by kazinol B in neutrophils.

Jih-Pyang Wang1, Mei-Feng Hsu, Horng-Huey Ko, Chun-Nan Lin.   

Abstract

Kazinol B, a natural isoprenylated flavan, stimulated the [Ca(2+)](i) elevation in the presence or absence of Ca(2+) in the medium. Treatment with chymotrypsin or phorbol 12-myristate 13-acetate to shedding of L: -selectin had no effect on subsequent kazinol B-induced Ca(2+) response. Upon initial cyclopiazonic acid (CPA) treatment in the absence of external Ca(2+), the subsequent [Ca(2+)](i) rise followed by challenge with kazinol B was greatly diminished. The ryanodine receptor blockers, 8-bromo-cyclic ADP-ribose and ruthenium red did not affect kazinol B-evoked Ca(2+) release from internal stores. However, the inhibitors of sphingosine kinase, dimethylsphingosine, but not dihydrosphingosine, inhibited kazinol B-induced Ca(2+) release. Kazinol B-induced [Ca(2+)](i) rise was not affected by two nitric oxidase inhibitors, N-(3-aminomethyl)benzylacetamidine (1400W) and 7-nitroindazole, cytochalasin B and Na(+)-deprivation. This response was slightly attenuated by 2-aminoethyldiphenyl borate (2-APB), a D: -myo-inositol 1,4,5-trisphosphate (IP(3)) receptor blocker, and by genistein, a general tyrosine kinase inhibitor. However, the Ca(2+) response was greatly diminished by two actin filament reorganizers, calyculin A and jasplakinolide, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY 294002), an inhibitor of phosphoinositide 3-kinase, N-(3-aminomethyl)benzylacetamidine (SB 203580), the p38 mitogen-activated protein kinase inhibitor, 1-[6-[17beta-3-methoxyestra-1,3,5(10)-trien-17-yl]amino]hexyl]-1H-pyrrole-2,5-dione (U-73122), the inhibitor of phospholipase C-coupled processes, and by 0.3 mM La(3+) or Ni(2+). Kazinol B did not evoke any appreciable Ba(2+) and Sr(2+) entry into cells. The Ca(2+) entry blockers, 1-[beta-[3-(4-methoxyphenyl)propoxy]-4-methoxyphenethyl]-1H-imidazole (SKF-96365), but not cis-N-(2-phenylcyclopentyl)azacyclotridec-1-en-2-amine (MDL-12,330A), inhibited a kazinol B-induced [Ca(2+)](i) rise. Kazinol B had no effect on the pharmacologically isolated plasma membrane Ca(2+)-ATPase activity. In a Ca(2+)-free medium, kazinol B inhibited the subsequent Ca(2+) addition, resulting in robust entry in CPA- and formyl peptide-activated cells. Kazinol B produced a concentration-dependent reduction in the mitochondrial membrane potential. These results indicate that kazinol B stimulates Ca(2+) release from internal Ca(2+) store, probably through the sphingosine 1-phosphate and IP(3) signaling, and activates external Ca(2+) influx mainly through a non-store-operated Ca(2+) entry (non-SOCE) pathway. Inhibition of SOCE by kazinol B is probably attributable to a break in the Ca(2+) driven force of mitochondria.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15558242     DOI: 10.1007/s00210-004-0997-3

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  44 in total

Review 1.  2-aminoethoxydiphenyl borate (2-APB) is a reliable blocker of store-operated Ca2+ entry but an inconsistent inhibitor of InsP3-induced Ca2+ release.

Authors:  Martin D Bootman; Tony J Collins; Lauren Mackenzie; H Llewelyn Roderick; Michael J Berridge; Claire M Peppiatt
Journal:  FASEB J       Date:  2002-08       Impact factor: 5.191

2.  The pyridinyl imidazole inhibitor SB203580 blocks phosphoinositide-dependent protein kinase activity, protein kinase B phosphorylation, and retinoblastoma hyperphosphorylation in interleukin-2-stimulated T cells independently of p38 mitogen-activated protein kinase.

Authors:  F V Lali; A E Hunt; S J Turner; B M Foxwell
Journal:  J Biol Chem       Date:  2000-03-10       Impact factor: 5.157

Review 3.  Capacitative calcium entry revisited.

Authors:  J W Putney
Journal:  Cell Calcium       Date:  1990 Nov-Dec       Impact factor: 6.817

4.  L-selectin stimulation of canine neutrophil initiates calcium signal secondary to tyrosine kinase activation.

Authors:  E Crockett-Torabi; J C Fantone
Journal:  Am J Physiol       Date:  1997-03

5.  Nitric oxide inhibits capacitative Ca2+ entry by suppression of mitochondrial Ca2+ handling.

Authors:  Baskaran Thyagarajan; Roland Malli; Kurt Schmidt; Wolfgang F Graier; Klaus Groschner
Journal:  Br J Pharmacol       Date:  2002-11       Impact factor: 8.739

6.  Human and rat neutrophils constitutively express neural nitric oxide synthase mRNA.

Authors:  S S Greenberg; J Ouyang; X Zhao; T D Giles
Journal:  Nitric Oxide       Date:  1998       Impact factor: 4.427

7.  A role for the actin cytoskeleton in the initiation and maintenance of store-mediated calcium entry in human platelets. Evidence for conformational coupling.

Authors:  J A Rosado; S Jenner; S O Sage
Journal:  J Biol Chem       Date:  2000-03-17       Impact factor: 5.157

8.  Thapsigargin activates univalent- and bivalent-cation entry in human neutrophils by a SK&F I3 96365- and Gd3+-sensitive pathway and is a partial secretagogue: involvement of pertussis-toxin-sensitive G-proteins and protein phosphatases 1/2A and 2B in the signal-transduction pathway.

Authors:  K Wenzel-Seifert; D Krautwurst; I Musgrave; R Seifert
Journal:  Biochem J       Date:  1996-03-01       Impact factor: 3.857

9.  The signal transduction mechanism involved in kazinol B-stimulated superoxide anion generation in rat neutrophils.

Authors:  J P Wang; L T Tsao; S L Raung; C N Lin
Journal:  Br J Pharmacol       Date:  1998-10       Impact factor: 8.739

10.  Sulfatides trigger increase of cytosolic free calcium and enhanced expression of tumor necrosis factor-alpha and interleukin-8 mRNA in human neutrophils. Evidence for a role of L-selectin as a signaling molecule.

Authors:  C Laudanna; G Constantin; P Baron; E Scarpini; G Scarlato; G Cabrini; C Dechecchi; F Rossi; M A Cassatella; G Berton
Journal:  J Biol Chem       Date:  1994-02-11       Impact factor: 5.157

View more
  2 in total

1.  Antagonism of human formyl peptide receptor 1 (FPR1) by chromones and related isoflavones.

Authors:  Igor A Schepetkin; Liliya N Kirpotina; Andrei I Khlebnikov; Ni Cheng; Richard D Ye; Mark T Quinn
Journal:  Biochem Pharmacol       Date:  2014-10-17       Impact factor: 5.858

Review 2.  Antagonism of human formyl peptide receptor 1 with natural compounds and their synthetic derivatives.

Authors:  Igor A Schepetkin; Andrei I Khlebnikov; Liliya N Kirpotina; Mark T Quinn
Journal:  Int Immunopharmacol       Date:  2015-09-15       Impact factor: 4.932

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.